EPISODE · Apr 30, 2020 · 10 MIN
Fed’s ‘medium-term’ warning, Microsoft growth, Barclays loan provisions
from FT News Briefing
The Federal Reserve has warned of lasting “medium-term” economic fallout from the coronavirus pandemic. The FT’s James Politi unpacks the central bank’s outlook. Plus, the White House praised Gilead’s remdesivir as a coronavirus treatment drug after the release of the findings from a new study, and Microsoft posted strong results in the latest quarter thanks to a jump in its cloud-related business. Then, the FT’s Stephen Morris reports on how Barclays fared in the first quarter as the bank announced a sharp increase in provisions for bad loans.To get free access to the FT’s Coronavirus Business Update newsletter for 30 days, visit ft.com/newsbriefingcovid. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The Federal Reserve has warned of lasting “medium-term” economic fallout from the coronavirus pandemic. The FT’s James Politi unpacks the central bank’s outlook. Plus, the White House praised Gilead’s remdesivir as a coronavirus treatment drug after the release of the findings from a new study, and Microsoft posted strong results in the latest quarter thanks to a jump in its cloud-related business. Then, the FT’s Stephen Morris reports on how Barclays fared in the first quarter as the bank announced a sharp increase in provisions for bad loans.To get free access to the FT’s Coronavirus Business Update newsletter for 30 days, visit ft.com/newsbriefingcovid. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Fed’s ‘medium-term’ warning, Microsoft growth, Barclays loan provisions
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m